Navigation Links
Albemarle Raises Prices of Specialty Aluminas
Date:11/30/2007

Increase Includes Flame Retardants, Fillers, Pigments and Ceramic Oxides

BATON ROUGE, La., Nov. 30 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB), the world leader in the development and marketing of aluminum trihydroxide and other specialty aluminas for flame retardants, fillers and other industrial applications, will increase the prices for all of its specialty aluminas up to 15 percent, effective globally on all shipment made on or after January 1, 2008, or as contracts allow. The increases are needed to help offset the rapidly escalating raw material prices, raw material freight costs and energy costs required to manufacture these products.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )

The price increases will take effect for all of the following products:

-- MARTINAL(R) aluminum trihydroxide (ATH) flame retardants

-- MARTIFIN(R) specialty alumina pigments

-- MARTOXID(R) aluminum oxide products

-- COMPALOX(R) activated aluminas

Plastics compounders and polymer manufacturers use Albemarle's MARTINAL flame retardants and technical services to add life-saving properties to wire & cable, roofing, flooring, pipe and other building and construction materials. MARTINAL fillers are also used to improve injection-molded plastic parts, insulating foams and certain electrical and electronic parts.

Albemarle's specialty ATH products are applied as pigmented fillers and coating minerals in the paper and board industry (MARTIFIN specialty pigments); as high-quality calcined aluminas for the industrial ceramics, refractory, and surface treatment industries (MARTOXID aluminum oxides); and as adsorbents and catalysts in chemical processes and environmental protection (COMPALOX activated aluminas).

Albemarle Corporation, headquartered in Richmond, Virginia, is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for consumer electronics; petroleum and petrochemical processing; transportation and industrial products; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments-Polymer Additives, Catalysts and Fine Chemicals, and serves customers in approximately 100 countries. Learn more about Albemarle at http://www.albemarle.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.


'/>"/>
SOURCE Albemarle Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Albemarle to Increase Price of Ibuprofen
2. Albemarle Reports Third Quarter 2007 Results
3. Albemarle to Raise Prices of Dibromomethane
4. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
5. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
6. Fifth Annual Avon Walk for Breast Cancer Los Angeles Raises $4.3 Million
7. AHIP Praises Bipartisan Senate Vote on Mental Health Parity
8. Union President Praises Hillary Clintons Health Plan
9. Progression of SIV infection in monkeys raises
10. Computerized Jump Rope Raises Funds for Breast Cancer Research
11. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America (BPC), ... reputable physician in their area, announces the launch of a new and proprietary customer ... are looking for reputable physicians to help them with back or neck pain and ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... Calif. , April 19, 2017  SARES•REGIS ... buildings it is developing at Conejo Spectrum Business ... , to Atara Biotherapeutics, Inc. , a ... severe and life-threatening diseases that have been underserved ... allogeneic T-cell therapies for cancer, autoimmune and infectious ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: